Knockdown of MAGEA6 Activates AMP-Activated Protein Kinase (AMPK) Signaling to Inhibit Human Renal Cell Carcinoma Cells

Background/Aims: Melanoma antigen A6 (MAGEA6) is a cancer-specific ubiquitin ligase of AMP-activated protein kinase (AMPK). The current study tested MAGEA6 expression and potential function in renal cell carcinoma (RCC). Methods: MAGEA6 and AMPK expression in human RCC tissues and RCC cells were tes...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Xueting Ye, Jing Xie, Hang Huang, Zhexian Deng
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Cell Physiol Biochem Press GmbH & Co KG 2018-02-01
coleção:	Cellular Physiology and Biochemistry
Assuntos:	Renal cell carcinoma MAGEA6 AMPK MTOR
Acesso em linha:	https://www.karger.com/Article/FullText/487452
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!